Atrial Shunt Therapy for Heart Failure: An Update

Area of Science:

• Cardiovascular Medicine
• Medical Devices
• Heart Failure Research

Background:

• Transcatheter atrial shunts are a novel therapeutic approach for heart failure (HF).
• These devices aim to reduce left atrial (LA) pressure by creating a shunt between the left and right atria.
• Over a decade of development has led to several devices and ongoing pivotal randomized clinical trials (RCTs).

Purpose of the Study:

• To provide a comprehensive review of atrial shunt therapeutics for heart failure.
• To describe current HF treatments, the rationale for atrial shunt development, and device designs.
• To discuss accumulated evidence, unanswered questions, and future considerations in the field.

Main Methods:

• Review of existing literature and clinical trial data on atrial shunt devices.
• Analysis of results from mechanistic and pivotal randomized clinical trials (RCTs).
• Identification of patient subgroups who may benefit from atrial shunt therapy.

Main Results:

• Two sham-controlled RCTs have been reported for the Atrial Shunt Device in HF with EF ≥ 40%.
• A mechanistic RCT showed reduced exercise LA pressure, while a pivotal RCT was neutral.
• Subgroup analysis of the pivotal RCT identified potential responders based on pulmonary vascular resistance and absence of cardiac rhythm management devices.

Conclusions:

• Atrial shunts represent a potential innovative therapy for heart failure.
• The optimal device design, procedural approach, and HF patient phenotype for benefit are yet to be determined.
• Further research and ongoing RCTs are crucial to confirm findings and guide clinical application.